SEC Form 4 · accession 0001179110-17-010741
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hubert L Allen
Officer — Executive Vice President
Period of report
Jul 25, 2017
Accepted (ET)
Jul 27, 2017 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Jul 25, 2017 | M | 4,600 | $26.6973 | A | 105,479 | D | |
| Common shares without par value | Jul 25, 2017 | S | 2,600 | $50.795 | D | 102,879 | D | |
| Common shares without par value | Jul 25, 2017 | S | 1,800 | $50.79 | D | 101,079 | D | |
| Common shares without par value | Jul 25, 2017 | S | 200 | $50.7922 | D | 100,879 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $26.6973 | Jul 25, 2017 | M | 4,600 | D | Feb 15, 2011 | Feb 14, 2018 | Common shares | 4,600 | 0 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).